Additional Information
Book Details
Abstract
Recognize and diagnose a wide range of renal pathologic entities with Diagnostic Atlas of Renal Pathology, 3rd Edition. In this edition, Drs. Agnes B. Fogo and Michael Kashgarian use hundreds of high-quality illustrations to clearly depict the pathologic features and clinical manifestations of both common and rare renal disorders. Extensive updates to the text keep you current with the knowledge you need for clinical practice or continuing education and certification.
- More than 700 images of light, immunofluorescence, and electron microscopy for each diagnostic entity with correlations to clinical presentation and pathogenesis.
- Focused, detailed discussions on key characteristic pathologic findings and prognostic, pathogenetic, and etiologic information.
- An in-depth examination of pathophysiology, clinical presentations, and the latest evidence-based practices.
- User-friendly format features tables and sidebars with key points and differential diagnoses, and chapters that include concise, templated discussions regarding the etiology and pathogenesis of the disorder.
- Consult this title on your favorite e-reader, conduct rapid searches, and adjust font sizes for optimal readability.
- A new chapter describing a logical approach to differential diagnosis.
- New insights into pathogenesis and classification of diseases.
- New coverage of aging and the kidney, endemic diseases, transplant, lupus-related kidney diseases, Mesoamerican nephropathy, ApolL1-related nephropathies, C3 glomerulopathies, and thrombotic microangiopathies.
- Recent results of consensus conferences on vasculitides and renal neoplasia.
Table of Contents
| Section Title | Page | Action | Price |
|---|---|---|---|
| Front Cover | Cover | ||
| IFC | ES1 | ||
| DIAGNOSTIC ATLAS OF RENAL PATHOLOGY | i | ||
| DIAGNOSTIC ATLAS OF RENAL PATHOLOGY | iii | ||
| Copyright | iv | ||
| Preface | v | ||
| Acknowledgments | vii | ||
| Contents | ix | ||
| DIAGNOSTIC ATLAS OF RENAL PATHOLOGY | xiii | ||
| 1 - Approach to Diagnosis of the Kidney Biopsy | 1 | ||
| 2 - Normal Growth and Maturation | 9 | ||
| 3 - Glomerular Diseases | 19 | ||
| Glomerular Diseases That Cause Nephrotic Syndrome: Non-Immune Complex | 20 | ||
| MINIMAL CHANGE DISEASE AND FOCAL SEGMENTAL GLOMERULOSCLEROSIS: INTRODUCTION | 20 | ||
| MINIMAL CHANGE DISEASE | 20 | ||
| Etiology/Pathogenesis | 22 | ||
| FOCAL SEGMENTAL GLOMERULOSCLEROSIS | 25 | ||
| Diagnosis of Recurrence of FSGS in the Transplant | 29 | ||
| Etiology/Pathogenesis | 34 | ||
| Collapsing Glomerulopathy | 37 | ||
| Etiology/Pathogenesis | 39 | ||
| Tip Lesion Variant of FSGS | 43 | ||
| Etiology/Pathogenesis | 45 | ||
| Cellular Variant of FSGS | 45 | ||
| Etiology/Pathogenesis | 46 | ||
| Perihilar Variant of FSGS | 46 | ||
| Etiology/Pathogenesis—Secondary Forms of FSGS | 47 | ||
| CONGENITAL NEPHROTIC SYNDROME OF FINNISH TYPE | 49 | ||
| Etiology/Pathogenesis | 50 | ||
| DIFFUSE MESANGIAL SCLEROSIS | 52 | ||
| Frasier Syndrome | 54 | ||
| Etiology/Pathogenesis | 55 | ||
| Glomerular Diseases That Cause Nephrotic/Nephritic Syndrome: Complement Related | 57 | ||
| C1Q NEPHROPATHY | 57 | ||
| Etiology/Pathogenesis | 58 | ||
| C3 GLOMERULOPATHIES | 59 | ||
| Dense Deposit Disease | 60 | ||
| Etiology/Pathogenesis | 61 | ||
| C3 Glomerulonephritis | 66 | ||
| Etiology/Pathogenesis | 69 | ||
| Glomerular Diseases That Cause Nephrotic Syndrome: Immune Complex | 71 | ||
| MEMBRANOUS NEPHROPATHY | 71 | ||
| Etiology/Pathogenesis | 82 | ||
| MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS | 88 | ||
| Etiology/Pathogenesis | 93 | ||
| FIBRILLARY GLOMERULONEPHRITIS | 100 | ||
| Etiology/Pathogenesis | 105 | ||
| IMMUNOTACTOID GLOMERULOPATHY | 108 | ||
| Etiology/Pathogenesis | 108 | ||
| Glomerular Diseases That Cause Hematuria or Nephritic Syndrome: Immune Complex | 112 | ||
| ACUTE POSTINFECTIOUS GLOMERULONEPHRITIS | 112 | ||
| Etiology/Pathogenesis | 115 | ||
| IGA NEPHROPATHY | 122 | ||
| Etiology/Pathogenesis | 129 | ||
| Secondary Glomerular Diseases | 134 | ||
| Diseases Associated With Nephrotic Syndrome | 134 | ||
| MONOCLONAL IMMUNOGLOBULIN DEPOSITION DISEASE | 134 | ||
| Light Chain Deposition Disease | 135 | ||
| Light and Heavy Chain Deposition Disease and Heavy Chain Deposition Disease | 140 | ||
| Etiology/Pathogenesis of MIDD | 146 | ||
| AMYLOIDOSIS | 147 | ||
| Etiology/Pathogenesis | 159 | ||
| PROLIFERATIVE GLOMERULONEPHRITIS WITH MONOCLONAL DEPOSITS | 161 | ||
| Etiology/Pathogenesis | 164 | ||
| HIV-ASSOCIATED NEPHROPATHY | 164 | ||
| Etiology/Pathogenesis | 169 | ||
| SICKLE CELL NEPHROPATHY | 170 | ||
| Etiology/Pathogenesis | 176 | ||
| FABRY DISEASE | 177 | ||
| Etiology/Pathogenesis | 182 | ||
| LIPOPROTEIN GLOMERULOPATHY | 183 | ||
| LECITHIN-CHOLESTEROL ACYLTRANSFERASE (LCAT) DEFICIENCY | 185 | ||
| Etiology/Pathogenesis | 187 | ||
| HEREDITARY FOCAL SEGMENTAL GLOMERULOSCLEROSIS | 188 | ||
| Diseases Associated With Nephritic Syndrome or Rapidly Progressive Glomerulonephritis (RPGN): Immune Mediated | 190 | ||
| LUPUS NEPHRITIS | 190 | ||
| Histopathology | 193 | ||
| Class I Minimal Mesangial Lupus Nephritis | 193 | ||
| Class II Mesangial Proliferative Lupus Nephritis | 193 | ||
| Class III Focal Lupus Nephritis | 197 | ||
| Class IV Diffuse Lupus Nephritis | 200 | ||
| Class V Membranous Lupus Nephritis | 207 | ||
| Class VI Advanced Sclerosing Lupus Nephritis | 209 | ||
| ATYPICAL PRESENTATIONS OF RENAL INVOLVEMENT IN SLE | 209 | ||
| Lupus Podocytopathy/Minimal Change Disease | 209 | ||
| ANCA-Associated Nephritis | 212 | ||
| Mixed Patterns and Transformation | 213 | ||
| Immunofluorescence Microscopic Features | 213 | ||
| Additional Pathologic Features | 214 | ||
| Vascular Lesions | 214 | ||
| Tubulointerstitial Disease | 215 | ||
| Assessment of Severity and Chronicity | 217 | ||
| Etiology/Pathogenesis | 218 | ||
| HENOCH–SCHÖNLEIN PURPURA (IGA VASCULITIS) | 219 | ||
| Etiology/Pathogenesis | 220 | ||
| MIXED CONNECTIVE TISSUE DISEASE | 230 | ||
| Etiology/Pathogenesis | 230 | ||
| MIXED CRYOGLOBULINEMIA | 236 | ||
| Etiology/Pathogenesis | 246 | ||
| ANTI-GBM ANTIBODY–MEDIATED GLOMERULONEPHRITIS | 246 | ||
| Etiology/Pathogenesis | 252 | ||
| Diseases Associated With the Nephritic Syndrome or RPGN: Antineutrophil Cytoplasmic Autoantibody (ANCA)–Associated Small-Vessel ... | 254 | ||
| INTRODUCTION | 254 | ||
| MICROSCOPIC POLYANGIITIS (MPA) | 256 | ||
| 4 - Vascular Diseases | 295 | ||
| Diabetic Nephropathy | 295 | ||
| Thrombotic Microangiopathy/Thrombotic Thrombocytopenic Purpura | 307 | ||
| Scleroderma (Systemic Sclerosis) | 321 | ||
| Antiphospholipid Antibody Disease | 328 | ||
| Preeclampsia and Eclampsia | 329 | ||
| PATHOLOGY | 329 | ||
| Etiology/Pathogenesis | 337 | ||
| Fibromuscular Dysplasia | 338 | ||
| PATHOLOGY | 338 | ||
| Arterionephrosclerosis | 343 | ||
| Accelerated/Malignant Hypertension | 354 | ||
| Atheroemboli | 359 | ||
| 5 - Tubulointerstitial Diseases | 365 | ||
| Introduction | 366 | ||
| Infections of the Kidney | 367 | ||
| Acute Pyelonephritis | 367 | ||
| Chronic Pyelonephritis and Reflux Nephropathy | 373 | ||
| Xanthogranulomatous Pyelonephritis | 376 | ||
| Malakoplakia | 378 | ||
| Acute Tubulointerstitial Nephritis—Viral Infection | 380 | ||
| Acute Tubulointerstitial Nephritis—Drug-Related | 380 | ||
| Tubulointerstitial Nephritis With Uveitis | 387 | ||
| Anti-Tubular Basement Membrane Antibody Nephritis | 388 | ||
| Idiopathic Hypocomplementemic Tubulointerstitial Nephritis | 390 | ||
| IgG4-Related Tubulointerstitial Nephritis | 391 | ||
| Interstitial Nephritis of Sjögren Syndrome | 396 | ||
| Sarcoidosis | 397 | ||
| Acute Kidney Injury/Acute Tubular Necrosis | 400 | ||
| ISCHEMIC ACUTE TUBULAR INJURY | 401 | ||
| ACUTE PHOSPHATE NEPHROPATHY | 408 | ||
| Etiology/Pathogenesis | 409 | ||
| NEPHROTOXIC ACUTE TUBULAR NECROSIS | 412 | ||
| Etiology/Pathogenesis | 414 | ||
| Warfarin-Induced Acute Kidney Injury/Anticoagulant-Related Nephropathy | 421 | ||
| Heavy Metal Nephropathy (Lead and Cadmium Nephropathy) | 421 | ||
| Analgesic Nephropathy and Papillary Necrosis | 422 | ||
| Light Chain Cast Nephropathy and Tubulopathy | 425 | ||
| Tubular Crystallopathies | 435 | ||
| CYSTINOSIS | 435 | ||
| Etiology/Pathogenesis | 437 | ||
| NEPHROCALCINOSIS | 440 | ||
| Etiology/Pathogenesis | 441 | ||
| OXALOSIS | 441 | ||
| Etiology/Pathogenesis | 443 | ||
| URATE NEPHROPATHY | 446 | ||
| Etiology/Pathogenesis | 446 | ||
| INDINAVIR NEPHROPATHY | 447 | ||
| Etiology/Pathogenesis | 448 | ||
| Lithium Nephropathy | 448 | ||
| Aristolochic Acid Nephropathy | 448 | ||
| 6 - Endemic Nephropathies | 449 | ||
| Introduction | 449 | ||
| Aristolochic Acid Nephropathy (Chinese Herb Nephropathy, Balkan Endemic Nephropathy) | 450 | ||
| Other Endemic Fibrosing Nephropathies | 451 | ||
| OCHRATOXIN NEPHROPATHY | 451 | ||
| CHRONIC KIDNEY DISEASE OF UNKNOWN ETIOLOGY IN SRI LANKA | 451 | ||
| MESOAMERICAN NEPHROPATHY | 452 | ||
| APOLIPOPROTEIN L1-ASSOCIATED NEPHROPATHIES | 453 | ||
| 7 - Chronic Kidney Disease | 457 | ||
| Introduction | 457 | ||
| Age-Related Sclerosis | 459 | ||
| Glomerular Versus Tubulointerstitial Versus Vascular Disease | 460 | ||
| Segmental Glomerulosclerosis: Primary Versus Secondary | 461 | ||
| 8 - Renal Transplantation | 463 | ||
| Introduction | 463 | ||
| Evaluation of Donor Kidneys | 466 | ||
| Antibody-Mediated Rejection | 467 | ||
| Chronic Active Antibody-Mediated Rejection and Transplant Glomerulopathy | 469 | ||
| Acute T Cell–Mediated Rejection | 471 | ||
| BORDERLINE CHANGES: “SUSPICIOUS FOR ACUTE REJECTION” | 471 | ||
| BANFF TYPE I ACUTE REJECTION | 472 | ||
| BANFF TYPE II ACUTE REJECTION | 473 | ||
| BANFF TYPE III ACUTE REJECTION | 473 | ||
| Chronic Active T–Cell Mediated Rejection | 476 | ||
| Cyclosporin/Tacrolimus Nephrotoxicity | 478 | ||
| Sirolimus (Rapamycin) Nephrotoxicity | 481 | ||
| Posttransplant Lymphoproliferative Disease | 481 | ||
| Viral Infections | 483 | ||
| Recurrent Renal Disease | 488 | ||
| 9 - Cystic Diseases of the Kidney | 491 | ||
| Introduction | 491 | ||
| Autosomal Dominant Polycystic Kidney Disease | 491 | ||
| Pathology | 492 | ||
| 10 - Renal Neoplasia | 511 | ||
| Introduction | 511 | ||
| Renal Neoplasms | 511 | ||
| BENIGN EPITHELIAL NEOPLASMS | 511 | ||
| RENAL CELL CARCINOMAS | 512 | ||
| Etiology/Pathogenesis | 524 | ||
| Nephroblastoma (Wilms Tumor) | 525 | ||
| Renal Angiomyolipoma | 528 | ||
| Urothelial (Transitional Cell) Carcinoma of the Renal Pelvis | 529 | ||
| Index | 531 | ||
| A | 531 | ||
| B | 532 | ||
| C | 532 | ||
| D | 534 | ||
| E | 534 | ||
| F | 535 | ||
| G | 536 | ||
| H | 536 | ||
| I | 537 | ||
| J | 538 | ||
| K | 538 | ||
| L | 539 | ||
| M | 540 | ||
| N | 541 | ||
| O | 541 | ||
| P | 541 | ||
| R | 543 | ||
| S | 543 | ||
| T | 544 | ||
| U | 545 | ||
| V | 545 | ||
| W | 546 | ||
| X | 546 | ||
| IBC | ES2 |